comparemela.com
Home
Live Updates
Phase 2 Trial Data Show That Novel Antibiotic Led to 96% Cure Rate for C diff Infection : comparemela.com
Phase 2 Trial Data Show That Novel Antibiotic Led to 96% Cure Rate for C diff Infection
Iberzaplstat was non-inferior to standard of care vancomycin, was safe and tolerable, and will advance into a phase 3 trial.
Related Keywords
United States
,
Jo Panuwat
,
Stuart Johnson
,
Robertj Deluccia
,
Kevin Garey
,
Acrux Pharmaceuticals
,
University Of Houston College Pharmacy
,
Us Centers For Disease
,
Loyola University
,
Pfizer
,
Acurx Scientific Advisory Board
,
Houston College
,
Disease Control
,
Awareness Month
,
comparemela.com © 2020. All Rights Reserved.